Company Name
Shanghai Trulive Medical Technology Co.,Ltd
Company Introduction
“Founded in 2019，Shanghai Trulive Medical Technology Co.,Ltd is an innovative healthcare platform, dedicating to help patients fight against vascular diseases.
We specialize in integrating cutting-edge medical technology with compassionate care to improve patient outcomes and quality of life.
We are concentrated on heart valves, peripheral vascular vessels, pulmonary artery and coronary arteries, making it one of the leading players offering a comprehensive solution for Vascular Diseases Patients.
Trulive Medical has achieved remarkable results owing to its highly experienced core team and rich medical industry background.
Awarded one of Top 100 unicorn enterprise, Trulive Medical has marketed several interventional therapy devices since 2024, including
DeepQuake, first-of-its-kind intravascular lithotripsy system with adjustable acoustic energy level
NeoNova, new generation TEER system for degenerative mitral regurgitation”
Size (number of persons)
60
Official website
www.trulive.cn
Contact person
Liao Xingzhong
Contact email
leo.l@trulive.cn
Product Name
- DeepQuake IVL syste
- NeoNova TEER System
Product Introduction + Highlights
- DeepQuake IVL System utilizes sonic pressure waves to treat calcified lesions in blood vessels.
This sytem is particularly beneficial for patients with coronary artery disease (CAD) and peripheral artery disease (PAD), conditions that can lead to serious cardiovascular complications.
Multiple acoustic energy levels enable therapists to crack severely calcium efficiently and effectively, particularly in some complex PCI cases.
Resilient catheter integrated with multiple emitters without compromising flexibility and profile
Innovative IC design offers uniform acoustic energy distribution to optimize therapeutic effect - The Trulive NeoNova TEER system is indicated for the percutaneous reduction of significant, symptomatic mitral regurgitation (MR ≥ 3+) due to primary abnormality of the mitral apparatus (degenerative MR) in patients.
Its innovative “Linear” clip design is able to reduce the crossing profile and prevent chordal interference for commissural lesions with complex sub-valvular anatomy.
Elastic Self-Locking mechanism effectively prevents leaflets laceration.
Up to 10mm wide clips facilitate challenging cases of extensive mitral valve prolapse
Smaller Radius Steering design lowers the risks of atrial dislodgement
Can the products be experienced on-site?
NO
Are the products certified in Thailand and Malaysia?
NO
Is the product leading in the industry?
YES
Have the products been exported to Europe, America or other countries?
NO
Demand for Exhibits
Reception Table （>1m long）
Catalogue holder